Li Yu - May 18, 2022 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
VP Cntrllr/Prncpl Acctng Offcr
Signature
/s/ Li Yu
Stock symbol
OCX
Transactions as of
May 18, 2022
Transactions value $
-$9,266
Form type
4
Date filed
5/19/2022, 05:58 PM
Previous filing
Mar 17, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Options Exercise $0 +25K $0.00 25K May 18, 2022 Direct
transaction OCX Common Stock, no par value Sale -$9.27K -8.13K -32.51% $1.14 16.9K May 18, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCX Restricted Stock Units Options Exercise $0 -25K -50% $0.00 25K May 18, 2022 Common Stock 25K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to cover the tax liability arising from the vesting of Restricted Stock Units.
F2 Restricted Stock Units vested on May 18, 2022.